Autoimmune polyendocrine syndrome caused by tislelizumab:one case report
As an anti-programmed death 1(PD-1)mono-clonal immunoglobulin G4 antibody,tislelizumab is com-monly applied for treating non-small cell lung cancer and uro-thelial carcinoma.In a female patient of advanced lung cancer on tirellizumab,autoimmune polyendocrine syndrome was accompanied by type 1 diabetes mellitus complicated with ketoacidosis and hypothyroidism.It helped to enhance clini-cians'understanding of rare adverse events caused by tislelizumab.
NETL
NSTL
万方数据
